Next-Generation Women's Health Supplement Formulations

Up to 40% of the global female population possesses a mutation in the MTHFR gene (such as C677T or A1298C), which significantly impairs the enzymatic conversion of synthetic folic acid into its biologically active form. L-5-MTHF bypasses this metabolic bottleneck completely, ensuring immediate cellular bioavailability, reducing un-metabolized folic acid (UMFA) accumulation in the bloodstream, and optimizing neural tube development parameters required by international health authorities.

Standard ferrous sulfate or ferrous fumarate frequently causes constipation, nausea, and oxidative degradation of co-formulated vitamins. Q Nutritions solves this using microencapsulated Ferric Pyrophosphate or Iron Bisglycinate Chelate. These liposomal and chelated matrices pass intact through the acidic stomach environment to be absorbed directly in the duodenum without mucosal irritation, iron taste, or oxidation of sensitive co-ingredients like Omega-3 or Folate.

Clinical literature demonstrates that the physiological ratio of 40:1 (Myo-Inositol to D-Chiro-Inositol) mimics the natural body fluid balance, optimizing oocyte quality, insulin sensitivity, and ovarian function. Q Nutritions engineers this exact 40:1 ratio into stable stick-pack powders, chewable tablets, and multi-particle HPMC capsules with validated blend uniformity.

Probiotic strains targeting female urogenital health—such as Lactobacillus rhamnosus GR-1® and Lactobacillus reuteri RC-14®—are highly sensitive to thermal exposure and humidity. We utilize Activ-Polymer™ desiccant packaging, low-aw (water activity < 0.15) excipient matrices, microencapsulation technologies, and nitrogen-purged blister packaging to ensure guaranteed colony-forming unit (CFU) counts through the 24-month declared shelf life.

Our dedicated regulatory team compiles comprehensive regulatory dossiers for over 40 export markets. This includes Health Canada Natural Product Numbers (NPN), US FDA Supplement Facts verification, EU Food Supplement notifications, GCC/UAE MOHAP registration dossiers, Free Sale Certificates (FSC), Certificates of Analysis (COA) per batch, and full stability testing data.

Commercial MOQs start at 1,000 units for standard capsules, tablets, and softgels; 5,000 units for pectin gummies; and 500 kg for powder blends. Pilot batches for stability testing and clinical trial validations can be produced at smaller scales. Standard turn-key lead times range from 6 to 8 weeks for private label stock formulas and 8 to 12 weeks for fully custom turnkey formulation development.

Lipid peroxidation is prevented through a multi-layer stabilization protocol: incorporating natural mixed tocopherols, rosemary extract, and ascorbyl palmitate into the oil phase, combined with nitrogen gas purging during encapsulation and primary packaging. Every oil batch is verified for Peroxide Value (PV) and Anisidine Value (AV) prior to product release.

Yes. We specialize in pectin-based, gelatin-free functional gummies formulated without sugar, artificial colors, or major allergens (soy, gluten, dairy). Utilizing maltitol or erythritol-monk fruit sweetener systems, our gummies maintain superior taste profiles while meeting clean-label retail requirements.